Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
Open Access
- 19 March 2015
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 9 (7) , 1259-1273
Abstract
Risk factors indicate the importance of oxidative stress during ovarian carcinogenesis. To tolerate oxidative stress, cells activate the transcription factor Nrf2 (Nfe2l2), the master regulator of antioxidant and cytoprotective genes. Indeed, for most cancers, hyperactivity of Nrf2 is observed, and siRNA studies assigned Nrf2 as therapeutic target. However, the cancer‐protective role of Nrf2 in healthy cells highlights the requirement for an adequate therapeutic window. We engineered artificial transcription factors to assess the role of Nrf2 in healthy (OSE‐C2) and malignant ovarian cells (A2780). Successful NRF2 up‐ and downregulation correlated with decreased, respectively increased, sensitivity toward oxidative stress. Inhibition of NRF2 reduced the colony forming potential to the same extent in wild‐type and BRCA1 knockdown A2780 cells. Only in BRCA1 knockdown A2780 cells, the effect of Nrf2 inhibition could be enhanced when combined with PARP inhibitors. Therefore, we propose that this combination therapy of PARP inhibitors and Nrf2 inhibition can further improve treatment efficacy specifically in BRCA1 mutant cancer cells without acquiring the side‐effects associated with previously studied Nrf2 inhibition combinations with either chemotherapy or radiation. Our findings stress the dual role of Nrf2 in carcinogenesis, while offering approaches to exploit Nrf2 as a potent therapeutic target in ovarian cancer.Keywords
Funding Information
- Netherlands Organization for Scientific Research (NWO) (728.011.101, 91786373)
This publication has 66 references indexed in Scilit:
- Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancerBMC Cancer, 2013
- The Involvement ofNRF2in Lung CancerOxidative Medicine and Cellular Longevity, 2013
- Oxidative stress and cancer: An overviewAgeing Research Reviews, 2013
- Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancerCancer Chemotherapy and Pharmacology, 2011
- Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative DisordersAntioxidants & Redox Signaling, 2010
- PARP inhibition: PARP1 and beyondNature Reviews Cancer, 2010
- TIF1β/KAP-1 Is a Coactivator of the Orphan Nuclear Receptor NGFI-B/Nur77Journal of Biological Chemistry, 2009
- Zinc-finger-based artificial transcription factors and their applicationsAdvanced Drug Delivery Reviews, 2009
- Dual roles of Nrf2 in cancerPharmacological Research, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001